1157P Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry

Autor: Hernando Cubero, J., Martinez Lago, N., Mitjavila, M., Garcia-Burillo, A., Pubul, V., Bello, P., Cano, J.M., Llana, B., Castellón, M., Rodeño, E., Piñeiro, A., Soldevilla, C., Nevares, M., Aller, J., Anido Herranz, U., Carnero Lopez, B., Nogareda, Z., Garcia Alvarez, A., Jimenez Fonseca, P., Capdevila Castillon, J.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S756-S756
Databáze: ScienceDirect